Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: Intrinsic differences and cell cycle effects

Carcinogenesis

Volumn 9, Issue 7, 1988, Pages 1283-1287

  Lewis, Alex D ^a   Hayes, John D ^b   Wolf, C Roland ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CISPLATIN; FLUOROURACIL; GLUTATHIONE; GLUTATHIONE TRANSFERASE;

CELL CULTURE; CELL CYCLE; DRUG RESISTANCE; FEMALE; HUMAN; HUMAN CELL; OVARY ADENOCARCINOMA;

ADENOCARCINOMA; CASE REPORT; CELL CYCLE; DRUG RESISTANCE; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HUMAN; OVARIAN NEOPLASMS;

EID: 0023942684     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/9.7.1283     Document Type: Article

References (54)

1. Stark G. and Calvert H. (eds) (1986) Cancer Surveys, Vol. 5
2. Kartner N., Shales M., Riordan J.R. and Ling V. (1983) Daunorubicinresistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein. Cancer Res., 43, 4413-4419.
3. Karran P. and Lindahl T. (1985) Cellular defence mechanisms against alkylating agents. Cancer Surveys, Vol. 4, (3) pp. 583-600.
4. Wolf C.R., Lewis A.D., Carmichael J., Ansell J., Adams D.J., Hickson I.D., Harris A., Balkwill F.R., Griffin D.B. and Hayes J.D. (1987) Glutathione-S-transferase expression in normal and tumour cells resistant to cytotoxic drugs. In Mantle, T.J., Pickett.C.B. and Hayes, J.D. (eds), Glutathione-S-transferases and Carcinogenesis, Taylor and Francis, London and New York, pp. 199-212.
5. Chasseaud L.F. (1979) The role of glutathione S-transferases in the metabolism of chemical carcinogens and other electrophilic agents. Adv. Cancer Res., 29, 175-275.
6. Larsson A., Orrenius S., Holmgren A. and Mannervik B. (eds) (1983)Functions of Glutathione; Biochemical, Physiological, Toxicological and Clinical Aspects. Raven Press, New York.
7. Hayes J.D. and Wolf C.R. (1988) Role of Glutathione Transferase in Drug Resistance. In Sies.H. and Ketterer.B. (eds), Mechanism and Biological Consequence of Glutathione Conjugation. Academic Press, in press.
8. Arrick B.I. and Nathan C.F. (1984) Glutathione metabolism as a determinant of therapeutic efficacy: a review. Cancer Res., 44, 4224-4232.
9. Russo A., Carmichael J., Friedman N., DeGraff W., Tochner Z., Glatstein E. and Mitchell J.B. (1986) The roles of intracellular glutathione in antineoplastic chemotherapy. Int. J. Radiat. Oncol. Biol. Phys., 12, 1347-1354.
10. Wolf C.R., Lewis A.D., Carmichael J., Adams D.J., AIlan S.G. and Ansell D.J. (1987) The role of glutathione in determining the response of normal and tumour cells to anticancer drugs. Biochem. Soc. Trans., 15, 728-730.
11. Adams D.J., Carmichael J. and Wolf C.R. (1985) Altered mouse bone marrow glutathione and glutathione transferase levels in response to cytotoxins. Cancer Res., 45, 1669-1673.
12. Batist G., Tulpule A., Sinha B., Katki A.G., Myers C.E. and Cowan K.H. (1986) Overexpression of a novel anionic glutathione-S-transferase in multidrug resistant human breast cancer cells. J. Biol. Chem., 261, 15544-15549.
13. Buller A.L., Clapper M.L. and Tew K.D. (1987) Glutathione-S-transferase in nitrogen mustard resistant and sensitive cell lines. Mol. Pharmacol., 31, 575-578.
14. McGowan A.T. and Fox B.W. (1986) A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitro. Cancer Chemother. Clin. Pharm., 17, 223-226.
15. Robson C.N., Lewis A.D., Wolf C.R., Hayes J.D., Hall A., Proctor S.J., Harris A.L. and Hickson I.D. (1987) Reduced levels of drug-induced DNA cross-linking in nitrogen mustard-resistant Chinese hamster ovary cells expressing elevated glutathione-S-transferase activity. Cancer Res., 47, 6022-6027.
16. Dulik D.M., Fenselau C. and Hilton J. (1986) Characterisation of melphalanglutathione adducts whose formation is catalysed by glutathione-S-transferase. Biochem. Pharm., 35, 3405-3409.
17. Mannervik B. (1985) Isoenzymes of glutathione-S-transferases. Adv. Enzymol., 57, 357-417.
18. Hayes J.D., McLellan L.I., Stockman P.K., Chalmers J. and Beckett G.J. (1987) Glutathione S-transferase in man. The relationship between rat and human enzymes. Biochem. Soc. Trans., 15, 721-725.
19. Hayes J.D., McLellan L.I., Stockman P.K., Howie A.F., Hussey A.J. and Beckett G.J. (1987) Human glutathione S-transferases: a polymorphic group of detoxification enzymes. In Mantle, T.J., Pickett, C.B. and Hayes, J.D. (eds), Glutathione S-transferases and Carcinogenesis. Taylor and Francis, London, New York, Philadelphia, pp. 3-18.
20. Kitahara A., Satoh K., Nishimura K., Ishikawa T., Ruike K., Sato K., Tsuda H. and Ito N. (1984) Changes in molecular forms of rat hepatic glutathione-S-transferases during chemical hepatocarcinogenesis. Cancer Res., 44, 2698-2703.
21. Carmichael J., Adams D.J., Ansell J. and Wolf C.R. (1986) Glutathione and glutathione transferase levels in mouse granulocytes following cyclophosamide administration. Cancer Res., 46, 735-739.
22. Sies H., Brigelius R., Wefers H., Muller A. and Cadenas E. (1983) Cellular redox changes and response to drugs and toxic agents. Fundam. Appl. Toxicol., 3, 200-208.
23. Orrenius S. and Moldeus P. (1984) The multiple roles of glutathione in drug metabolism. Trends. Pharm. Sci., 5, 432-435.
24. Meyers C.E. (1982) Anthracyclines. In Chabner.B.A. (ed.), Pharmacologic Principles of Cancer Treatment. W.F. Saunders, Philadelphia, pp. 416-434.
25. Wolf C.R., Hayward I.P., Lawrie S.S., Buckton K., McIntyre M.A., Adams D.J., Lewis A.D., Scott A.R.R. and Smyth J.F. (1987) Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient. Int. J. Cancer, 39, 695-702.
26. O’Hara H. and Terasima T. (1969) Variations of cellular sulfhydryl content during the cell cycle of HeLa cells and its correlation to cyclic change of X-ray sensitivity. Exp. Cell. Res., 58, 182-185.
27. Watanabe M. and Horikawa M. (1975) Analyses of differential sensitivities of synchronised HeLa S3 cells to radiation and chemical carcinogens during the cell cycle. II. 4-Nitroquinoline 1-oxide and its derivatives. Mutat. Res.,28, 295-304.
28. Frei J.V. and Harsano T. (1967) Increased susceptibility to low doses of a carcinogen of epidermal cells in stimulated DNA synthesis. Cancer Res., 27, 1482-1484.
29. Balkwill F.R. and Bokhonik O. (1984) Differential effects of pure human alpha and gamma interferons on fibroblast cell growth and the cell cycle. Exp. Cell. Res., 155, 190-197.
30. Heyns A., du P., Eldor A., Vlodavsky I., Kaiser N., Fridman R. and Panet A. (1985) The antiproliferative effect of interferon and the mitogenic activity of growth factors are independent cell cycle events. Exp. Cell Res., 16, 229-306.
31. Gaetjens E.C, Chen P. and Broome J.D. (1984) L1210(A) Mouse lymphoma cells depleted of glutathione with buthionine-S-R-sulphoximine proliferate in tissue culture. Biochem. Biophys. Res. Commun., 123, 626-632.
32. Habig W.H., Pabist M.J. and Jackoby W.B. (1974) Glutathione transferases. The first enzymatic step in mercapuric acid formation. J. Biol. Chem., 249, 7130-7139.
33. Stockman P.K., McLellan L.I. and Hayes J.D. (1987) Characterisation of basic glutathione-S-transferase Bl and B2 subunits from human liver. Biochem. J., 244, 55-61.
34. Weiss C, Maker H.S. and Lehrer G.M. (1980) Sensitive fluorometric assays for glutathione peroxidase and reductase. Anal. Biochem., 106, 512-516.
35. Richman P. and Meister A. (1975) Regulation of y glutamylcysteine synthetase by nonallosteric feedback inhibition by glutathione. J. Biol. Chem., 250, 1422-1426.
36. Seelig G.F. and Meister M. (1984) g-Glutamylcysteine synthetase: Interactions of an essential sulphydryl group. J. Biol. Chem., 259, 3534-3538.
37. Smith G.D., Ding J.L. and Peters J.J. (1979) A sensitive fluorimetric assay for gamma glutamyl transpeptidase. Anal. Biochem., 100, 136-139.
38. Lowry O.H., Rosebrough N.J., Farr A.L. and Randall R.J. (1951) Protein measurements with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
39. Towbin H., Staehelin T. and Gordon J. (1979) Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: Procedures and some applications. Proc. Natl. Acad. Sci. USA, 76, 4350-4354.
40. Adams D.J., Seilman S., Amelizad Z., Oesch F. and Wolf C.R. (1985) Identification of human cytochrome P-450 analogous to forms induced by phenobarbital and 3-methylcholanthrene in the rat. Biochem. J., 232, 869-876.
41. Hayes J.D., Gilligan D., Chapman B.J. and Beckett G.J. (1983) Purification of human hepatic glutathione-S-transferase and the development of a radioimmunoassay for their measurement in plasma. Clin. Chim. Acta., 134, 107-121.
42. Faber E. (1984) The biochemistry of preneoplastic liver: a common metabolic pattern in hepatocyte nodules. Can. J. Biochem. Cell. Biol., 62, 486-494.
43. Andrews P.A., Murphy M.P. and Howell S.B. (1985) Differential potentiation of alkylating and platinating agent cytotoxicity in human ovarian carcinoma cells by glutathione depletion. Cancer Res., 45, 6250-6253.
44. Andrews P.A., Murphy M.P. and Howell S.B. (1986) Differential sensitivity of human ovarian carcinoma and mouse L1210 cells to ci's platinum and melphalan by glutathione depletion. Mol. Pharmacol., 30, 643-650.
45. Louie K.G., Behrens B.C, Kinsella T.J., Hamilton T.C, Grotzinger K.R., McKoy W.M., Winker M.A. and Ozols R.R. (1985) Radiation survival parameters of antineoplastic drug sensitive and resistant human ovarian cancer cell lines and their modification by buthionine sulphoximine. Cancer Res., 45, 2110-2115.
46. Green J.A., Vistica R.C, Young R.C, Hamilton T.C, Rogan A.M. and Ozols R.F. (1984) Potentiation of melphalan cytotoxicity in human ovarian cell lines by glutathione depletion. Cancer Res. 44, 5427-5431.
47. Hamilton T.C, Winker M.A., Louie K.G., Batist G., Behrens B.C, Tsurvo T., Grotzinger K.R., McKoy W.M., Young R.C. and Ozols R.F.(1985) Augmentation of adriamycin, melphalan and cis platinum cytotoxicity in drug resistant and sensitive human ovarian cancer cell lines by buthionine sulphoximine-mediated depletion of glutathione. Biochem. Pharmacol., 4, 2583-2586.
48. Teicher B.A., Holden S.A., Kelley M.J., Shea T.C, Cucchi C.A., Rosowsky A., Henner W.D. and Frei III E. (1987) Characterization of a human squamous carcinoma cell line resistant to cw-diamminedihloroplatinum( II). Cancer Res., 47, 388-393.
49. Griffith O.W. and Meister A. (1979) Glutathione: interorgan translocation, turnover and metabolism. Proc. Nail. Acad. Sci. USA, 76, 5606-5610.
50. Ahmad S., Okine L., Wood R., Aljian J. and Vistica D.T. (1987) g-Glutamyltranspeptidase (gGT) and maintenance of thiol pools in tumour cells resistant to alkylating agents. Cell. Physioi, 131, 240-246.
51. Meister A. (1983) Metabolism and transport of glutathione and other g-glutamyl compounds. In Larrson.A., Orrenius.S., Holmgren, A. and Mannervick B. (eds), Functions of Glutathione: Biochemical, Physiological, Toxicological and Clinical Aspects. Raven Press, New York, pp. 1 -22.
52. Smith C.V., Hughes H., Lauterburg B.H. and Mitchell J.R. (1983) Chemical nature of reactive metabolites determines their biological interactions with glutathione. In Larsson.A., Holmgren.A., Orrenius, S. and Mannervik.B. (eds), Functions of Glutathione: Biochemical, Physiological, Toxicological and Clinical Aspects. Raven Press, New York, pp. 125-137.
53. Dunn C.D.R. (1972) Cell proliferation and drug resistance in the response of colony forming units of rat bone marrow to repeated doses of cytotoxic agents. J. Nail. Cancer Inst., 48, 639-649.
54. Fohlmeister I., Hohentanner O. and Porr A. (1984) S phase resistance of rat hematopoietic stem cells to 7,12-dimethylbenz[a]anthracene cytocide and its implications for leukemia development. Cancer Res., 44, 3661-3664.